Viyash Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 758.75 Cr
as on 31-08-2024
- Paid Up Capital ₹ 334.38 Cr
as on 31-08-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 35.44 Cr
as on 31-08-2024
- Revenue 6.21%
(FY 2024)
- Profit 65.13%
(FY 2024)
- Ebitda 120.21%
(FY 2024)
- Net Worth -0.63%
(FY 2024)
- Total Assets -2.03%
(FY 2024)
About Viyash Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 758.75 Cr and a paid-up capital of Rs 334.38 Cr.
The company currently has active open charges totaling ₹35.44 Cr.
The Key Managerial Personnel (KMP) at Viyash Life Sciences Private Limited India are Hari Bodepudi as CEO and Janaki Seethanaboina as Company Secretary. Kamal Sharma, Pradip Kanakia, Kalidindi Raju, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2019PTC130774
- Company No.
130774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2019
- Date of AGM
22 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Viyash Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hari Bodepudi | CEO | 22-Jun-2021 | Current |
Janaki Seethanaboina  | Company Secretary | 09-Oct-2019 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Kaul  | Nominee Director | 04-Jan-2023 | Current |
| Kamal Sharma | Director | 01-Dec-2022 | Current |
| Gurveen Singh | Director | 24-Mar-2022 | Current |
| Pradip Kanakia | Nominee Director | 20-Dec-2021 | Current |
| Kalidindi Raju | Whole-Time Director | 07-Aug-2019 | Current |
| Hari Bodepudi | Whole-Time Director | 21-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Viyash Life Sciences.
Viyash Life Sciences Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.21% increase. The company also saw a substantial improvement in profitability, with a 65.13% increase in profit. The company's net worth dipped by a decrease of 0.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viyash Life Sciences?
In 2023, Viyash Life Sciences had a promoter holding of 11.97% and a public holding of 88.02%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vindhya Pharma (India) Private LimitedActive 18 years 4 months
Kalidindi Raju and Hari Bodepudi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Oct 2022 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 26 Nov 2021 | ₹2.40 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Mar 2021 | ₹1.81 M | Open |
How Many Employees Work at Viyash Life Sciences?
Unlock and access historical data on people associated with Viyash Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viyash Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viyash Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
